Sosei Group Corp.

Sosei Group Corp.
Stock Exchange Other OTC
EPS
$0.85
Market Cap
$1.64 B
Shares Outstanding
19.05 M
Public Float
-
Sosei Group Corp.
Stock Exchange Tokyo Stock Exchange
EPS
JPY94.81
Market Cap
JPY178.59 B
Shares Outstanding
76.38 M
Public Float
67.05 M

Profile

Address
PMO Hanzomon, 11/F
Tokyo Tokyo 102
Japan
Employees -
Website http://www.sosei.com
Updated 07/08/2019
Sosei Group Corp. engages in the discovery, design, and development of medicines targeting G protein-coupled receptors (GPCRs). Its proprietary StaR (Stabilised Receptor) technology and structure-based drug design (SBDD) platform enables development of drugs for highly validated, yet historically undruggable or challenging GPCRs. The company has multiple programs targeting Alzheimer's disease, schizophrenia, immuno-oncology, migraine, metabolic disease and other rare and specialty indications.

Financials

View All

Shinichi Tamura
Chairman
Peter James Jonathan Bains
President, Chief Executive Officer & Director